Computational Drug Development (CDD) for Biologics 2022 - Harnessing AI for De Novo Antibody Design

Skip to content

872e1f14-65fb-479b-abb0-b226eedbe363

Event Ran | October 23 – 24, 2024 | Boston, MA

2024 EVENT GUIDE

Home
About
- About Event
- Hanson Wade
Program
- 2024 Event Guide
- 2024 Speakers
Partnerships
Take part
- Register Interest
- Contact Us

Harnessing AI for De Novo Antibody Design

Time: 9:00 am
day: Day One

Speakers:

Philip Kim

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences	Beacon
Searchlight	Intelligence

SEARCH

Search

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

HWG

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.